The trial is designed to evaluate safety and clinical response rates in patients with rheumatoid arthritis. Small Modular ImmunoPharmaceutical (SMIP) drugs represent a novel class of immunotherapeutics that
China Biopharma owns 65% of the joint venture and its partner, Zhejiang Tianyuan Bio-Pharmaceutical, owns the remaining 35%. In June 2006, the Chinese government approved ZT Biotech for
Early versions of Novavax's HIV virus-like particle (VLP) vaccine were successful in triggering immune responses in preclinical studies. However, Novavax recently discovered a way to optimize the expression
Clinical trial supplies have been shipped, and patient recruitment has commenced for the trial of the drug, NE-180. The phase II trial is designed as an ascending dose
Phenoptin is being developed in partnership with BioMarin, for the treatment of patients with phenylketonuria (PKU), a rare genetic disorder where sufferers have a deficiency of an enzyme
The drug, MN-001, was well-tolerated but did not show a statistically significant clinical benefit compared to placebo on the primary endpoint at the doses tested in this trial.
Under the terms of the agreement, Pfizer will pay Genizon upfront license fees and funding for research on genetic variations associated with diseases. Pfizer will also purchase an
Priority Review is granted to products that would provide a significant improvement in the safety or effectiveness of the treatment, diagnosis or prevention of a serious disease. The
The trial is being conducted in conjunction with the TIMI Study Group at Harvard Medical School and Brigham and Women's Hospital. The phase III study is designed to
Currently, there are no marketed therapies specifically indicated for prevention of re-infection post-liver transplant in HCV-positive patients. Nabi Biopharmaceuticals is co-developing Civacir with Italian biopharmaceutical company Kedrion. Kedrion
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.